Idera Pharmaceuticals, Inc. (IDRA): Price and Financial Metrics
GET POWR RATINGS... FREE!
IDRA Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for IDRA is -10.06 -- better than only 1.79% of US stocks.
- IDRA's price/sales ratio is 43.02; that's higher than the P/S ratio of 95.46% of US stocks.
- As for revenue growth, note that IDRA's revenue has grown 255.77% over the past 12 months; that beats the revenue growth of 97.36% of US companies in our set.
- Stocks that are quantitatively similar to IDRA, based on their financial statements, market capitalization, and price volatility, are SURF, NXTC, MVIS, CRUS, and MCRB.
- IDRA's SEC filings can be seen here. And to visit Idera Pharmaceuticals Inc's official web site, go to www.iderapharma.com.
IDRA Stock Price Chart Interactive Chart >
IDRA Price/Volume Stats
|Current price||$0.69||52-week high||$6.14|
|Prev. close||$0.69||52-week low||$0.60|
|Day high||$0.69||Avg. volume||1,799,488|
|50-day MA||$0.91||Dividend yield||N/A|
|200-day MA||$1.53||Market Cap||36.43M|
Idera Pharmaceuticals, Inc. (IDRA) Company Bio
Idera Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. The company was founded in 1989 and is based in Cambridge, Massachusetts.
Most Popular Stories View All
IDRA Latest News Stream
|Loading, please wait...|
IDRA Latest Social Stream
View Full IDRA Social Stream
Latest IDRA News From Around the Web
Below are the latest news stories about Idera Pharmaceuticals Inc that investors may wish to consider to help them evaluate IDRA as an investment opportunity.
Tarsus Pharmaceuticals (NASDAQ:TARS) and Idera Pharmaceuticals (NASDAQ:IDRA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation. Analyst Recommendations This is a summary of recent recommendations for Tarsus Pharmaceuticals and Idera Pharmaceuticals, 
Idera Pharmaceuticals (NASDAQ:IDRA) and Tarsus Pharmaceuticals (NASDAQ:TARS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability and earnings. Analyst Ratings This is a summary of current ratings and price targets for Idera Pharmaceuticals 
EXTON, Pa., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its financial and operational results for the third quarter ended September 30, 2021. “We are maintaining our focus on identifying new development or commercial-stage assets for Idera’s portfolio and we are encouraged by the opportunities presented to us,” stated Vincent Milano, Idera’s Chief Executive Officer. “As a number of these prospects adva
Idera Pharmaceuticals (NASDAQ:IDRA) and Bavarian Nordic A/S (OTCMKTS:BVNRY) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, risk and institutional ownership. Insider and Institutional Ownership 11.7% of Idera Pharmaceuticals shares are held by institutional investors. 5.1% 
In last trading session, Idera Pharmaceuticals Inc. (NASDAQ:IDRA) saw 0.42 million shares changing hands with its beta currently measuring 1.71. Companys recent per share price level of $0.88 trading at $0.0 or -0.64% at ring of the bell on the day assigns it a market valuation of $47.61M. That closing price of IDRAs stock is Idera Pharmaceuticals Inc. (NASDAQ:IDRA): -597.73% Off High, Can It Comeback? Read More »
IDRA Price Returns
Continue Researching IDRAWant to see what other sources are saying about Idera Pharmaceuticals Inc's financials and stock price? Try the links below:
Idera Pharmaceuticals Inc (IDRA) Stock Price | Nasdaq
Idera Pharmaceuticals Inc (IDRA) Stock Quote, History and News - Yahoo Finance
Idera Pharmaceuticals Inc (IDRA) Stock Price and Basic Information | MarketWatch